Yahoo Web Search

Search results

    • Biogen (NASDAQ:BIIB) Price Target Cut to $214.00

      ETF DAILY NEWS· 5 days ago

      Biogen (NASDAQ:BIIB – Get Free Report) had its price target reduced by equities research analysts at UBS Group from $250.00 to $214.00 in a research note issued on Wednesday, Benzinga reports ...